KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Finished Goods (2020 - 2023)

Historic Finished Goods for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q2 2023 value amounting to $4.4 million.

  • Ginkgo Bioworks Holdings' Finished Goods fell 4105.53% to $4.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was $4.4 million, marking a year-over-year decrease of 4105.53%. This contributed to the annual value of $6.6 million for FY2022, which is 10085.78% up from last year.
  • Ginkgo Bioworks Holdings' Finished Goods amounted to $4.4 million in Q2 2023, which was down 4105.53% from $5.3 million recorded in Q1 2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Finished Goods registered a high of $8.0 million during Q1 2022, and its lowest value of $2.5 million during Q3 2021.
  • In the last 4 years, Ginkgo Bioworks Holdings' Finished Goods had a median value of $5.3 million in 2023 and averaged $5.1 million.
  • Its Finished Goods has fluctuated over the past 5 years, first soared by 12065.56% in 2022, then tumbled by 4105.53% in 2023.
  • Ginkgo Bioworks Holdings' Finished Goods (Quarter) stood at $2.8 million in 2020, then increased by 18.43% to $3.3 million in 2021, then soared by 100.86% to $6.6 million in 2022, then plummeted by 32.35% to $4.4 million in 2023.
  • Its Finished Goods stands at $4.4 million for Q2 2023, versus $5.3 million for Q1 2023 and $6.6 million for Q4 2022.